UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~April~~May 3022, 2025

PULMONX CORPORATION

(Exact name of Registrant as Specified in Its Charter)


Delaware		001-39562	77-0424412
(State or Other Jurisdiction		(Commission File Number)	(IRS Employer
of Incorporation)			Identification No.)
700 Chesapeake Drive
Redwood City,	CA		94063
(Address of Principal Executive Offices)			(Zip Code)

(650)364-0400

Registrant's telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

LUNG

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 25.0207 ~~Results~~Submission of ~~Operations~~Matters ~~and~~to ~~Financial~~a ~~Condition~~Vote of Security Holders.

On ~~April~~May 3022, 2025, Pulmonx Corporation (the “Company”) ~~issued~~held aits ~~press~~2025 ~~release~~Annual ~~announcing~~Meeting ~~its~~of ~~financial~~Stockholders ~~results~~(the ~~for~~“Annual Meeting”). A total of 33,322,365 shares of the ~~first~~Company’s ~~fiscal~~common ~~quarter~~stock ~~ended~~were ~~March~~present 31or represented by proxy at the Annual Meeting, ~~2025.~~which Arepresented ~~copy~~approximately 82.79% of the Company’s ~~press~~40,247,480 ~~release~~shares ~~dated~~of ~~April~~common 30stock that were outstanding and entitled to vote at the meeting as of the record date of March 25, 2025. At the Annual Meeting, ~~titled~~the ~~“Pulmonx~~stockholders ~~Reports~~of ~~First~~the ~~Quarter~~Company ~~2025~~considered ~~Financial~~the ~~Results”~~three proposals outlined below, each of which is ~~attached~~described ~~hereto~~in asmore ~~Exhibit~~detail ~~99.1~~in the Company’s definitive proxy statement filed with the Securities and isExchange ~~incorporated~~Commission ~~herein~~on byApril ~~reference~~8, 2025 (the “Proxy Statement”).

~~The~~Proposal ~~foregoing~~1 ~~information~~– ~~(including~~Election ~~the exhibit hereto) is being furnished under “Item 2.02 Results~~ of Operations and Financial Condition” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.Directors

~~Item~~The ~~9.01~~stockholders ~~Financial~~elected ~~Statements~~each of the three nominees for Class II director to serve until the Company’s 2028 Annual Meeting of Stockholders and ~~Exhibits~~until their successor has been elected and qualified. The voting results were as follows:

(d)Exhibits.


	For	Withheld	Broker Non-Votes
Richard M. Ferrari	16,967,158	11,954,625	4,400,582
Daniel P. Florin	21,067,949	7,853,834	4,400,582
Steven S. Williamson	21,336,518	7,585,265	4,400,582

Exhibit No.						Description
99.1						Press release dated April 30, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm

The stockholders ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. The voting results were as follows:


For	Against	Abstain
33,032,895	282,772	6,698

There were no broker non-votes with respect to Proposal 2.

Proposal 3 – Non-Binding Advisory Vote to Approve the Company’s Executive Compensation

The stockholders approved, on a non-binding advisory basis, the Company’s executive compensation as disclosed in the Proxy Statement. The voting results were as follows:


For	Against	Abstain	Broker Non-Votes
14,708,726	14,202,629	10,428	4,400,582

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Pulmonx Corporation

Dated: ~~April~~May 3022, 2025

By: /s/ ~~Mehul~~David ~~Joshi~~Lehman ~~Mehul~~David ~~Joshi~~Lehman ~~Chief~~General ~~Financial Officer~~Counsel

Filing Compare · Pulmonx Corp